Granulocytosis: Difference between revisions
No edit summary |
(No difference)
|
Revision as of 17:11, 25 April 2012
WikiDoc Resources for Granulocytosis |
Articles |
---|
Most recent articles on Granulocytosis Most cited articles on Granulocytosis |
Media |
Powerpoint slides on Granulocytosis |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Granulocytosis at Clinical Trials.gov Trial results on Granulocytosis Clinical Trials on Granulocytosis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Granulocytosis NICE Guidance on Granulocytosis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Granulocytosis Discussion groups on Granulocytosis Patient Handouts on Granulocytosis Directions to Hospitals Treating Granulocytosis Risk calculators and risk factors for Granulocytosis
|
Healthcare Provider Resources |
Causes & Risk Factors for Granulocytosis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Overview
- Granulocytosis is defined as the presence of an increased number of granulocytes, a category of white blood cells present in the peripheral blood. Often, the word refers to an increased neutrophil granulocyte count, as neutrophils are the main granulocytes.
- An increase in eosinophil granulocyte is known as eosinophilia.
- Granulocytosis can be a feature of a number of diseases:
- Infection, especially bacterial
- Malignancy, most notably leukemia (it is the main feature of chronic myelogenous leukemia, CML)
- Autoimmune disease
- In cardiovascular disease, increased white blood cell counts have been shown to indicate a worse prognosis.